Biocon Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 39,537 million compared to INR 29,411 million a year ago. Revenue was INR 45,192 million compared to INR 30,197 million a year ago. Net income was INR 6,600 million compared to net loss of INR 418 million a year ago. Basic earnings per share from continuing operations was INR 5.52 compared to basic loss per share from continuing operations of INR 0.35 a year ago. Diluted earnings per share from continuing operations was INR 5.51 compared to diluted loss per share from continuing operations of INR 0.35 a year ago.
For the nine months, sales was INR 108,386 million compared to INR 74,003 million a year ago. Revenue was INR 116,555 million compared to INR 76,213 million a year ago. Net income was INR 8,870 million compared to INR 1,495 million a year ago. Basic earnings per share from continuing operations was INR 7.42 compared to INR 1.25 a year ago. Diluted earnings per share from continuing operations was INR 7.41 compared to INR 1.25 a year ago.